New open access journal on malaria

Download PDF Copy

Aug 22 2011

NewsGuard 100/100 Score

A post in the "Malaria Matters" blog announces "a new open access journal on malaria: Malaria Chemotherapy, Control and Elimination," which "has been recently launched by Ashdin Publishing." According to the blog, "[t]he journal aims to bridge basic and applied malaria research in tropical and other settings" (Brieger, 8/21).

This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Posted in: Disease/Infection News | Healthcare News

Tags: Chemotherapy, Health Care, Malaria, Research

Comments (0)

Download PDF Copy

Suggested Reading

A promising new strategy for malaria drug development

A promising new strategy for malaria drug development

Surge in malaria cases linked to aircraft-transported mosquitoes

Surge in malaria cases linked to aircraft-transported mosquitoes

Study finds artemisinin resistance in African children with severe malaria

Study finds artemisinin resistance in African children with severe malaria

Egypt achieves historic malaria-free certification

Egypt achieves historic malaria-free certification

Uncovering the secrets of malaria parasite cell division

Uncovering the secrets of malaria parasite cell division

New drug MED6-189 shows promise against drug-resistant malaria

New drug MED6-189 shows promise against drug-resistant malaria

New test promises to end malaria

New test promises to end malaria

Breakthrough discovery could lead to novel malaria vaccines and therapies

Breakthrough discovery could lead to novel malaria vaccines and therapies

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

Maternal antibodies may hinder malaria vaccine effectiveness in infants